IP Verse

Mylan Pharmaceuticals competitive analysis

Latest publications and patents of Mylan Pharmaceuticals New

Explore the latest publications and patents granted to Mylan Pharmaceuticals, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Mylan Pharmaceuticals

Discover the latest PTAB cases involving Mylan Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 30, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Mylan Pharmaceuticals

IPR2023-00724Mar 16, 2023MYLAN PHARMACEUTICALSNOVO NORDISKTerminated-Settled
IPR2023-00722Mar 16, 2023MYLAN PHARMACEUTICALSNOVO NORDISKInstitution Denied
IPR2023-00723Mar 16, 2023MYLAN PHARMACEUTICALSNOVO NORDISKInstitution Denied
IPR2023-00099Oct 28, 2022MYLAN PHARMACEUTICALSREGENERON PHARMACEUTICALSInstitution Denied
IPR2022-01226Jul 1, 2022MYLAN PHARMACEUTICALSREGENERON PHARMACEUTICALSFinal Written Decision
IPR2022-01225Jul 1, 2022MYLAN PHARMACEUTICALSREGENERON PHARMACEUTICALSFinal Written Decision
IPR2022-01102Jun 10, 2022MYLAN PHARMACEUTICALSBAUSCH HEALTH IRELANDInstitution Denied
IPR2022-01103Jun 10, 2022MYLAN PHARMACEUTICALSBAUSCH HEALTH IRELANDInstitution Denied
IPR2022-01104Jun 10, 2022MYLAN PHARMACEUTICALSBAUSCH HEALTH IRELANDInstitution Denied
IPR2022-01105Jun 10, 2022MYLAN PHARMACEUTICALSBAUSCH HEALTH IRELANDInstitution Denied

Peer Comparison New

IP litigation analysis comparing Mylan Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
MYLAN PHARMACEUTICALS - - 94 - Highly Aggressive
ALLERGAN11281333Balanced
ASTRAZENECA AB - - - 18Non-Active
SANOFI AVENTIS DEUTSCHLAND1629 - 24Balanced